PubRank

Dusan Turk

Author PubWeight™ 32.94‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Averaged kick maps: less noise, more signal... and probably less bias. Acta Crystallogr D Biol Crystallogr 2009 3.62
2 Interpretation of ensembles created by multiple iterative rebuilding of macromolecular models. Acta Crystallogr D Biol Crystallogr 2007 3.07
3 Emerging roles of cysteine cathepsins in disease and their potential as drug targets. Curr Pharm Des 2007 2.26
4 Cystatins: biochemical and structural properties, and medical relevance. Front Biosci 2008 1.52
5 Crystal structure of Stefin A in complex with cathepsin H: N-terminal residues of inhibitors can adapt to the active sites of endo- and exopeptidases. J Mol Biol 2003 1.24
6 Essential role of proline isomerization in stefin B tetramer formation. J Mol Biol 2006 1.23
7 Regulating cysteine protease activity: essential role of protease inhibitors as guardians and regulators. Curr Pharm Des 2002 1.23
8 Monitoring compartment-specific substrate cleavage by cathepsins B, K, L, and S at physiological pH and redox conditions. BMC Biochem 2009 1.21
9 Two-step membrane binding by Equinatoxin II, a pore-forming toxin from the sea anemone, involves an exposed aromatic cluster and a flexible helix. J Biol Chem 2002 1.20
10 Lysosomal cathepsins: structure, role in antigen processing and presentation, and cancer. Adv Enzyme Regul 2002 1.08
11 Pore formation by equinatoxin, a eukaryotic pore-forming toxin, requires a flexible N-terminal region and a stable beta-sandwich. J Biol Chem 2004 1.03
12 Autocatalytic processing of procathepsin B is triggered by proenzyme activity. FEBS J 2009 1.02
13 Inhibitory fragment from the p41 form of invariant chain can regulate activity of cysteine cathepsins in antigen presentation. J Biol Chem 2008 0.96
14 PURY: a database of geometric restraints of hetero compounds for refinement in complexes with macromolecular structures. Acta Crystallogr D Biol Crystallogr 2008 0.94
15 Two decades of thyroglobulin type-1 domain research. Biol Chem 2007 0.91
16 The role of cathepsin C in Papillon-Lefèvre syndrome, prepubertal periodontitis, and aggressive periodontitis. Hum Mutat 2004 0.90
17 Recombinant human cathepsin X is a carboxymonopeptidase only: a comparison with cathepsins B and L. Biol Chem 2005 0.87
18 The mechanism of amyloid-fibril formation by stefin B: temperature and protein concentration dependence of the rates. Proteins 2009 0.87
19 Versatile loops in mycocypins inhibit three protease families. J Biol Chem 2009 0.85
20 Size and morphology of toxic oligomers of amyloidogenic proteins: a case study of human stefin B. Amyloid 2008 0.85
21 4-Substituted trinems as broad spectrum beta-lactamase inhibitors: structure-based design, synthesis, and biological activity. J Med Chem 2007 0.85
22 Different propensity to form amyloid fibrils by two homologous proteins-Human stefins A and B: searching for an explanation. Proteins 2004 0.84
23 Essential role of Pro 74 in stefin B amyloid-fibril formation: dual action of cyclophilin A on the process. FEBS Lett 2009 0.83
24 Folding and amyloid-fibril formation for a series of human stefins' chimeras: any correlation? Proteins 2006 0.82
25 Crystal structure of NS-134 in complex with bovine cathepsin B: a two-headed epoxysuccinyl inhibitor extends along the entire active-site cleft. Biochem J 2004 0.81
26 Unnatural amino acids increase activity and specificity of synthetic substrates for human and malarial cathepsin C. Amino Acids 2014 0.81
27 Mouse stefins A1 and A2 (Stfa1 and Stfa2) differentiate between papain-like endo- and exopeptidases. FEBS Lett 2006 0.79
28 Crystallization and preliminary X-ray crystallographic analysis of the cysteine protease inhibitor clitocypin. Acta Crystallogr Sect F Struct Biol Cryst Commun 2005 0.77
29 Mo6S9-xIx nanowire recognitive molecular-scale connectivity. Nano Lett 2007 0.75